Evotec SE
XTRAEVT cost to borrow surges 289% in one week to 5.70%, signaling acute short squeeze pressure on the German biotech firm as shares become scarcer to borrow.
Snapshot as of 28 Jun 2026
No long-form analysis yet for EVT. Pulse alerts and the live data picture are available on ORTEX.
Open EVT on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for EVT — free to start on ORTEX.
Sign up for free →Open EVT on ORTEX